VERA
Vera Therapeutics Inc
NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY
$34.00
-0.79% today
Updated 2026-09-18
Market cap
$2.43B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.87
Dividend yield
—
52W range
$23 – $56
Volume
2.3M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.5
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
1.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →253 stocks currently score above 75
Price targets
Analyst target
$77.64
+128.35%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.18x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 1.13 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-100.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $1.86M | $0.00 | $0.00 | $0.00 |
| Net income | $-89.06M | $-95.99M | $-152.15M | $-299.62M | $-109.47M |
| EPS | — | — | — | — | $-5.87 |
| Free cash flow | $-67.66M | $-92.24M | $-135.65M | $-241.73M | $-100.40M |
| Profit margin | — | -5,155.21% | — | — | — |
Peer comparison
Smart narrative
Vera Therapeutics Inc trades at $34.00. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.13, it sits in the distress.
Frequently asked questions
What is Vera Therapeutics Inc's stock price?
Vera Therapeutics Inc (VERA) trades at $34.00.
Is Vera Therapeutics Inc overvalued?
Vera Therapeutics Inc carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Vera Therapeutics Inc (VERA)?
The 12-month analyst consensus target is $77.64, about 128.4% above the current $34.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Vera Therapeutics Inc's Altman Z-Score is 1.13, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-73.84%
Beta0.95
50D MA$35.55
200D MA$39.50
Shares out0.07B
Float0.05B
Short ratio—
Avg volume2.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—